Found: 2
Select item for more details and to access through your institution.
Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib.
- Published in:
- Therapeutic Advances in Hematology, 2014, v. 5, n. 4, p. 121, doi. 10.1177/2040620714539906
- By:
- Publication type:
- Article
Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations.
- Published in:
- Therapeutic Advances in Hematology, 2014, v. 5, n. 4, p. 107, doi. 10.1177/2040620714537865
- By:
- Publication type:
- Article